1147 related articles for article (PubMed ID: 6151891)
1. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
2. Comparison of labetalol with other anti-hypertensive drugs.
Prichard BN; Richards DA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive drugs in pregnancy.
Naden RP; Redman CW
Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
[TBL] [Abstract][Full Text] [Related]
4. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
6. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
8. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
9. Labetalol in long-term treatment of hypertension.
Prichard BN; Boakes AJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
[TBL] [Abstract][Full Text] [Related]
10. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
Lamming GD; Broughton Pipkin F; Symonds EM
Clin Exp Hypertens (1978); 1980; 2(5):865-95. PubMed ID: 7428566
[TBL] [Abstract][Full Text] [Related]
13. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
Michelson EL; Frishman WH
Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
[TBL] [Abstract][Full Text] [Related]
14. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
Stummvoll HK
Wien Med Wochenschr Suppl; 1981; 69():14-6. PubMed ID: 6123200
[No Abstract] [Full Text] [Related]
15. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
[TBL] [Abstract][Full Text] [Related]
16. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
MacCarthy EP; Bloomfield SS
Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
[TBL] [Abstract][Full Text] [Related]
17. Use of labetalol and methyldopa in pregnancy-induced hypertension.
Lamming GD; Symonds EB
Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
[TBL] [Abstract][Full Text] [Related]
18. Labetalol in hypertension.
Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
[No Abstract] [Full Text] [Related]
19. Hypertension in pregnancy. Pathophysiology and management.
Lubbe WF
Drugs; 1984 Aug; 28(2):170-88. PubMed ID: 6147240
[TBL] [Abstract][Full Text] [Related]
20. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
